Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12008)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2017 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hackett G, Jones PW, Strange RC, Ramachandran S. Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes. World J Diabetes 2017; 8(3): 104-111 [PMID: 28344753 DOI: 10.4239/wjd.v8.i3.104] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v8/i3/104.htm |
| Number | Citing Articles |
| 1 |
Farid Saad. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Advances in Experimental Medicine and Biology 2017; 1043: 527 doi: 10.1007/978-3-319-70178-3_23
|
| 2 |
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, Giovanni Rossini, Virginia Zamponi, Soraya Olana, Antongiulio Faggiano, Paolo Pozzilli, Andrea M. Isidori, Daniele Gianfrilli. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes/Metabolism Research and Reviews 2022; 38(2) doi: 10.1002/dmrr.3494
|
| 3 |
Sudarshan Ramachandran, Carola S. König, Geoffrey Hackett, Mark Livingston, Richard C. Strange. Managing Clinical Heterogeneity: An Argument for Benefit-Based Action Limits. Journal of Engineering and Science in Medical Diagnostics and Therapy 2018; 1(3) doi: 10.1115/1.4039561
|
| 4 |
Zhonglin Cai, Jianzhong Zhang, Hongjun Li. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases. Cardiovascular Drugs and Therapy 2019; 33(1): 119 doi: 10.1007/s10557-019-06851-7
|
| 5 |
Michael Kirby, Geoffrey Hackett, Sudarshan Ramachandran. Testosterone and the Heart. European Cardiology Review 2019; 14(2): 103 doi: 10.15420/ecr.2019.13.1
|
| 6 |
Geoff Hackett, Michael Kirby, David Edwards, Thomas Hugh Jones, Kevan Wylie, Nick Ossei-Gerning, Janine David, Asif Muneer. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, with Statements for UK Practice. The Journal of Sexual Medicine 2017; 14(12): 1504 doi: 10.1016/j.jsxm.2017.10.067
|
| 7 |
Irina Khripun, Sergey Vorobyev, Igor Belousov, Michel Kogan, Michael Zitzmann. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial. The Aging Male 2019; 22(4): 241 doi: 10.1080/13685538.2018.1506918
|
| 8 |
Sudarshan Ramachandran, Geoffrey I. Hackett, Richard C. Strange. Testosterone replacement therapy: Pre‐treatment sex hormone‐binding globulin levels and age may identify clinical subgroups. Andrology 2020; 8(5): 1222 doi: 10.1111/andr.12813
|
| 9 |
Yuliya Tishova, Svetlana Kalinchenko, George Mskhalaya, Geoffrey Hackett, Mark Livingston, Carola König, Richard Strange, Michael Zitzmann, Amar Mann, Amro Maarouf, Sudarshan Ramachandran. Testosterone therapy reduces insulin resistance in men with adult‐onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open‐label phase. Diabetes, Obesity and Metabolism 2024; 26(6): 2147 doi: 10.1111/dom.15520
|
| 10 |
S. Ramachandran, R. C. Strange, A. A. Fryer, F. Saad, G. I. Hackett. The association of sex hormone‐binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes. Andrology 2018; 6(6): 846 doi: 10.1111/andr.12520
|
| 11 |
Sumon Roy, Robert A. Kloner, Fadi N. Salloum, Ion S. Jovin. Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety. Cardiovascular Drugs and Therapy 2023; 37(4): 793 doi: 10.1007/s10557-021-07275-y
|
| 12 |
Mark D. Peterson, Aleksandr Belakovskiy, Ryan McGrath, Joshua F. Yarrow. Testosterone Deficiency, Weakness, and Multimorbidity in Men. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24347-6
|
| 13 |
Richard C. Strange, Carola S. König, Adeeba Ahmed, Geoff Hackett, Ahmad Haider, Karim S. Haider, Pieter Desnerck, Farid Saad, Nathan Lorde, Amro Maarouf, Sudarshan Ramachandran. Testosterone Therapy: Increase in Hematocrit is Associated with Decreased Mortality. Androgens: Clinical Research and Therapeutics 2021; 2(1): 150 doi: 10.1089/andro.2021.0019
|
| 14 |
Katya B. Rubinow, Jing H. Chao, Derek Hagman, Mario Kratz, Brian Van Yserloo, Nilesh W. Gaikwad, John K. Amory, Stephanie T. Page. Circulating sex steroids coregulate adipose tissue immune cell populations in healthy men. American Journal of Physiology-Endocrinology and Metabolism 2017; 313(5): E528 doi: 10.1152/ajpendo.00075.2017
|
| 15 |
Daria Khaltourina, Yuri Matveyev, Aleksey Alekseev, Franco Cortese, Anca Ioviţă. Aging Fits the Disease Criteria of the International Classification of Diseases. Mechanisms of Ageing and Development 2020; 189: 111230 doi: 10.1016/j.mad.2020.111230
|
| 16 |
Robert A. Kloner, Irwin Goldstein, Michael G. Kirby, John D. Parker, Richard Sadovsky. Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market. Sexual Medicine Reviews 2018; 6(4): 583 doi: 10.1016/j.sxmr.2018.03.008
|
| 17 |
Mark Livingston, Paul Downie, Geoff Hackett, Rachel Marrington, Adrian Heald, Sudarshan Ramachandran. An audit of the measurement and reporting of male testosterone levels in UK clinical biochemistry laboratories. International Journal of Clinical Practice 2020; 74(11) doi: 10.1111/ijcp.13607
|
| 18 |
Tobias S. Köhler, Robert A. Kloner, Raymond C. Rosen, Arthur L. Burnett, Michael J. Blaha, Peter Ganz, Irwin Goldstein, Noel N. Kim, Tom Lue, Kevin T. McVary, John P. Mulhall, Sharon J. Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira D. Sharlip, Martin Miner. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings 2024; 99(9): 1500 doi: 10.1016/j.mayocp.2024.06.002
|
| 19 |
Geoffrey Hackett. Type 2 Diabetes and Testosterone Therapy. The World Journal of Men's Health 2019; 37(1): 31 doi: 10.5534/wjmh.180027
|
| 20 |
Carola S. König, Stavroula Balabani, Geoffrey I. Hackett, Richard C. Strange, Sudarshan Ramachandran. Testosterone Therapy: An Assessment of the Clinical Consequences of Changes in Hematocrit and Blood Flow Characteristics. Sexual Medicine Reviews 2019; 7(4): 650 doi: 10.1016/j.sxmr.2019.01.003
|
| 21 |
Adrian H. Heald, Ghasem Yadegar far, Mark Livingston, Helene Fachim, Mark Lunt, Ram Prakash Narayanan, Kirk Siddals, Gabriela Moreno, Richard Jones, Nagaraj Malipatil, Martin Rutter, Martin Gibson, Rachelle Donn, Geoff Hackett, Hugh Jones. Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort study. Cardiovascular Endocrinology & Metabolism 2020; 10(1): 37 doi: 10.1097/XCE.0000000000000230
|
| 22 |
Robert A Kloner, Arthur L Burnett, Martin Miner, Michael J Blaha, Peter Ganz, Irwin Goldstein, Noel N Kim, Tobias Kohler, Tom Lue, Kevin T McVary, John P Mulhall, Sharon J Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira D Sharlip, Raymond C Rosen. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. The Journal of Sexual Medicine 2024; 21(2): 90 doi: 10.1093/jsxmed/qdad163
|
| 23 |
Ye Feng, Xi Jin, Jing Zhu, Meng Yuan, Liang Zhu, Dan Ye, Yuqing Shen. Association between endogenous estradiol, testosterone, and long‐term mortality in adults with prediabetes and diabetes: Evidence from NHANES database. Journal of Diabetes Investigation 2024; doi: 10.1111/jdi.14367
|
| 24 |
Stergios Soulaidopoulos, Dimitrios Terentes-Printzios, Nikolaos Ioakeimidis, Konstantinos P Tsioufis, Charalambos Vlachopoulos. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy 2024; 10(5): 403 doi: 10.1093/ehjcvp/pvae029
|
| 25 |
Mark Livingston, Adrian Heald, Geoffrey Hackett, Harishnath Ramachandran, Sudarshan Ramachandran. Is there an association between daylight hours and serum testosterone levels in men?. The Aging Male 2024; 27(1) doi: 10.1080/13685538.2024.2409189
|
| 26 |
Sudarshan Ramachandran, Geoffrey I. Hackett, Richard C. Strange. Sex Hormone Binding Globulin: A Review of its Interactions With Testosterone and Age, and its Impact on Mortality in Men With Type 2 Diabetes. Sexual Medicine Reviews 2019; 7(4): 669 doi: 10.1016/j.sxmr.2019.06.006
|
| 27 |
C. Burté, H. Lejeune, A. Faix, P. Desvaux, T. Almont, B. Cuzin, E. Huyghe. Les recommandations pour la prise en charge du déficit en testostérone. Sexologies 2021; 30(3): 149 doi: 10.1016/j.sexol.2021.06.006
|
| 28 |
Jong-Dai Kim. Diabetes and Sexual Dysfunction. The Journal of Korean Diabetes 2023; 24(1): 18 doi: 10.4093/jkd.2023.24.1.18
|
| 29 |
Shikhar Tripathi, M. Elakiya, Alka Mishra, Dhastagir Sultan Sherrif. A perspective on diabetes-related hypogonadism. Current Medicine Research and Practice 2021; 11(2): 88 doi: 10.4103/cmrp.cmrp_3_21
|
| 30 |
Steven G. Chrysant, George S. Chrysant. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone. Hospital Practice 2018; 46(2): 47 doi: 10.1080/21548331.2018.1445405
|
| 31 |
Amar Mann, Richard C Strange, Carola S König, Geoffrey Hackett, Ahmad Haider, Karim Sultan Haider, Peter Desnerck, Sudarshan Ramachandran. Testosterone replacement therapy: association with mortality in high‐risk patient subgroups. Andrology 2024; 12(6): 1389 doi: 10.1111/andr.13582
|
| 32 |
C. Burte, H. Lejeune, A. Faix, P. Desvaux, T. Almont, B. Cuzin, E. Huyghe. Recommandations pratiques pour la prise en charge du déficit en testostérone. Progrès en Urologie 2021; 31(8-9): 458 doi: 10.1016/j.purol.2020.09.026
|
| 33 |
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange, Sudarshan Ramachandran. Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function. The World Journal of Men's Health 2020; 38(1): 68 doi: 10.5534/wjmh.180052M
|
| 34 |
Mark Livingston, Anura Kalansooriya, Andrew J. Hartland, Sudarshan Ramachandran, Adrian Heald. Serum testosterone levels in male hypogonadism: Why and when to check-A review. International Journal of Clinical Practice 2017; 71(11): e12995 doi: 10.1111/ijcp.12995
|
| 35 |
Jose Antonio Santos-Marcos, Marina Mora-Ortiz, Manuel Tena-Sempere, Jose Lopez-Miranda, Antonio Camargo. Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases. Biology of Sex Differences 2023; 14(1) doi: 10.1186/s13293-023-00490-2
|
| 36 |
Robert A. Kloner, Eric Stanek, Karishma Desai, Christopher L. Crowe, Kathryn Paige Ball, Aaron Haynes, Raymond C. Rosen. The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunction. Clinical Cardiology 2024; 47(2) doi: 10.1002/clc.24234
|
| 37 |
Amar Mann, Richard C. Strange, Geoffrey Hackett, Carola König, Sudarshan Ramachandran. Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition. Exploration of Endocrine and Metabolic Diseases 2024; 1(3): 83 doi: 10.37349/eemd.2024.00010
|
| 38 |
G. Hackett, N. Cole, A. Saghir, P. Jones, R. C. Strange, S. Ramachandran. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30‐week randomized placebo‐controlled study. Andrology 2017; 5(5): 905 doi: 10.1111/andr.12399
|
| 39 |
Nathan Lorde, Amro Maarouf, Richard C. Strange, Carola S. König, Geoff Hackett, Ahmad Haider, Karim Sultan Haider, Pieter Desnerck, Farid Saad, Sudarshan Ramachandran. Testosterone Therapy in Adult-Onset Testosterone Deficiency: Hematocrit and Hemoglobin Changes. Androgens: Clinical Research and Therapeutics 2021; 2(1): 141 doi: 10.1089/andro.2021.0013
|
| 40 |
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange, Sudarshan Ramachandran. Long‐term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU International 2019; 123(3): 519 doi: 10.1111/bju.14536
|
| 41 |
Federica Barbagallo, Federica Campolo, Edoardo Franceschini, Elena Crecca, Riccardo Pofi, Andrea M. Isidori, Mary Anna Venneri. PDE5 Inhibitors in Type 2 Diabetes Cardiovascular Complications. Endocrines 2020; 1(2): 90 doi: 10.3390/endocrines1020009
|
| 42 |
Raymond C Rosen, Martin Miner, Arthur L Burnett, Michael J Blaha, Peter Ganz, Irwin Goldstein, Noel Kim, Tobias Kohler, Tom Lue, Kevin McVary, John Mulhall, Sharon J Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira Sharlip, Robert A Kloner. Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium. Sexual Medicine Reviews 2024; 12(4): 681 doi: 10.1093/sxmrev/qeae043
|